Light therapy may ease recovery for blood cancer patients

NCT ID NCT05737732

First seen Jun 13, 2026 · Last updated Jun 19, 2026 · Updated 1 time

Summary

This study tests whether carefully timed lighting can help multiple myeloma patients undergoing their first stem cell transplant. Two hundred participants will receive either bright morning light and dim evening light, or dim light all day. Researchers will measure sleep quality, inflammation, fever, and symptoms over two months to see if the lighting schedule improves recovery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Icahn Schoool of Medicine at Mount Sinai

    RECRUITING

    New York, New York, 10029, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact

    Contact Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Circadian Effective Lighting (special light bulbs and schedules)

What this could lead to

If it works, this could offer a simple, drug-free way to help multiple myeloma patients sleep better, feel less fatigued, and recover more comfortably after a stem cell transplant.

What could go wrong

This is an early-stage study testing a non-drug intervention, so the benefits may be small or not show up at all. The results may not apply to all patients or settings.

Conditions

The condition(s) this trial relates to.

Multiple Myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.